We are live on ! Find out more
VXRT

Vaxart
VXRT

Delisted

VXRT was delisted on the 7th of July, 2025.

Back to rankings

32 hedge funds and large institutions have $6.17M invested in Vaxart in 2017 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 6

0.82% less ownership

Funds ownership: 2.99% → 2.17% (-0.82%)

14% less funds holding

Funds holding: 37 → 32 (-5)

25% less capital invested

Capital invested by funds: $8.27M → $6.17M (-$2.1M)

56% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 9

Holders
32
Holders Change
-5
Holders Change %
-13.51%
% of All Funds
0.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
7
Reduced
6
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$610K
2
Renaissance Technologies
Renaissance Technologies
New York
+$188K
3
VKH
Virtu KCG Holdings
New York
+$121K
4
CCM
Carlson Capital Management
Minnesota
+$85.1K
5
Deutsche Bank
Deutsche Bank
Germany
+$76.2K

Top Sellers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
-$2.07M
2
SAM
Senzar Asset Management
New York
-$1.13M
3
SCM
Stonepine Capital Management
Oregon
-$205K
4
BlackRock
BlackRock
New York
-$57.9K
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$52K
Name Holding Trade Value Shares
Change 		Change in
Stake
KAM
1
Krensavage Asset Management
New York
$1.9M – – –
AC
2
Armistice Capital
New York
$752K +$610K +102,075 New
Renaissance Technologies
3
Renaissance Technologies
New York
$708K +$188K +31,372 +48%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$673K +$1.55K +259 +0.3%
Vanguard Group
5
Vanguard Group
Pennsylvania
$668K -$43.9K -7,336 -7%
BlackRock
6
BlackRock
New York
$324K -$57.9K -9,686 -18%
GCIA
7
Gabelli & Co Investment Advisers
New York
$150K – – –
VKH
8
Virtu KCG Holdings
New York
$149K +$121K +20,267 New
BCM
9
Bridgeway Capital Management
Texas
$137K – – –
TL
10
TowerView LLC
New York
$117K -$2.72K -455 -3%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$112K -$6.18K -1,033 -6%
CCM
12
Carlson Capital Management
Minnesota
$105K +$85.1K +14,226 New
Deutsche Bank
13
Deutsche Bank
Germany
$93K +$76.2K +12,741 +637,050%
California Public Employees Retirement System
14
California Public Employees Retirement System
California
$66K – – –
GF
15
Gabelli Funds
New York
$42K – – –
Northern Trust
16
Northern Trust
Illinois
$41K – – –
TRCT
17
Tower Research Capital (TRC)
New York
$33K +$24.9K +4,162 +1,347%
PNC Financial Services Group
18
PNC Financial Services Group
Pennsylvania
$23K – – –
State Street
19
State Street
Massachusetts
$15K – – –
GC
20
Guggenheim Capital
Illinois
$14K – – –
UBS Group
21
UBS Group
Switzerland
$12K +$9.11K +1,524 +2,381%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$10K -$2.22K -372 -22%
WS
23
Wedbush Securities
California
$9K +$1.97K +330 +35%
RJFSA
24
Raymond James Financial Services Advisors
Florida
$8K – – –
Morgan Stanley
25
Morgan Stanley
New York
$6K -$263 -44 -5%
1
2

VXRT Hedge Fund Activity: Q2 2017 in Review

32 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q2 2017, worth a combined $6.17M — down 25% from $8.27M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of VXRT and 4 opened new positions — a net loss of 5 holders — while 6 trimmed existing stakes and 7 added.

The largest buyer was Armistice Capital, opening a new position worth an estimated $610K. The largest seller was Broadfin Capital, exiting entirely with an estimated $2.07M sold.

  • 32 institutional investors held Vaxart (VXRT) as of Q2 2017, down from 37 in Q1 2017.
  • Funds reported $6.17M of Vaxart stock for Q2 2017, down 25% quarter-over-quarter.
  • 4 funds opened new Vaxart positions in Q2 2017 and 9 closed out, a net change of -5 holders.
  • The largest Vaxart buyer in Q2 2017 was Armistice Capital, an estimated $610K added.
  • The largest Vaxart seller in Q2 2017 was Broadfin Capital, an estimated $2.07M sold.

Based on aggregated 13F filings for Q2 2017.